|
시장보고서
상품코드
2055301
컴피턴트 셀 시장 : 세포 유형별, 생물 유형별, 용도별, 컴피턴시레벨별, 최종사용자별, 지역별Competent Cells Market, By Cell Type, By Organism Type, By Application, By Competency Level, By End User, By Geography |
||||||
컴피턴트 셀 시장은 2026년 27억 3,000만 달러로 추정되고, 2033년에 54억 5,000만 달러에 이를 것으로 예상되고 있습니다. 또한, 2026-2033년 CAGR 10.4%를 기록할 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준연도 : | 2025년 | 2026년 시장 규모 : | 27억 3,000만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR : | 10.40% | 2033년 시장 규모 예측 : | 54억 5,000만 달러 |
세계 컴피턴트 셀 시장은 생명공학 및 제약 산업에서 중요한 분야로, 분자생물학의 응용 및 유전공학 공정에서 기초적인 도구로 활용되고 있습니다. 유능 세포(competent cell)란 DNA에 대한 투과성을 높이기 위해 화학적 또는 물리적으로 처리된 세균 세포로, 연구자가 형질전환 절차를 통해 외래 유전 물질을 도입할 수 있게 해줍니다. 이러한 특수 세포들은 클로닝, 단백질 발현, 플라스미드 증식 등 현대 생명공학 연구 개발의 기반을 이루는 다양한 재조합 DNA 기술에서 필수적인 역할을 수행하고 있습니다.
이 시장에는 화학적 컴피턴트 셀이나 전기적 컴피턴트 셀 등 다양한 유형의 컴피턴트 셀이 포함되어 있으며, 각각은 일상적인 클로닝부터 고효율 형질전환에 이르기까지 특정 용도에 맞추어 설계되었습니다. 유전체 연구 범위의 확대, 맞춤형 의료의 발전, 생명공학 분야의 혁신에 따라, 신뢰성이 높고 효율적인 유능 세포 시스템에 대한 수요는 전 세계적으로 계속해서 급증하고 있습니다. 학술 연구 기관, 제약 회사, 생명공학 기업, 수탁 연구 기관이 주요 최종 사용자이며, 치료법 개발 및 과학 연구 분야의 획기적인 발견을 촉진하는 분자 클로닝 도구와 유전자 조작 기술에 대한 지속적인 수요를 통해 시장 성장을 주도하고 있습니다.
시장 역학
세계 컴피턴트 셀 시장은 연구 및 상업적 용도에서의 확장을 전반적으로 뒷받침하는 몇 가지 주요 촉진요인에 의해 주도되고 있습니다. 유전체학 및 단백질체학 연구에 대한 투자 증가와 더불어, 혁신적인 치료 솔루션이 필요한 유전성 질환의 유병률 상승이 시장 발전의 주요 성장 동력이 되고 있습니다. 합성생물학 접근법, CRISPR-Cas9 유전자 편집 기술, 맞춤형 의료의 도입 확대는 복잡한 유전자 조작을 가능하게 하는 고품질 유능 세포에 대한 수요를 크게 증가시키고 있습니다. 또한, 특히 신흥국에서의 생명공학 부문 확대는 시장 진출과 수익 창출을 위한 큰 기회를 제공합니다. 그러나 유전자 연구나 생명공학의 응용을 규제하는 엄격한 법적 규제 등, 시장에는 뚜렷한 제약도 존재합니다. 이는 제품 승인을 지연시키고, 제조업체의 규정 준수 비용 증가로 이어질 수 있습니다.
유능한 세포의 콜드체인 물류 및 보관 요건을 유지하는 데 따르는 높은 비용은 특히 예산이 제한적인 소규모 연구 기관에게 있어 또 다른 과제가 되고 있습니다. 또한, 컴피턴트 셀을 다루는 데 있어 기술적인 복잡성과 전문 지식이 필요하다는 점 때문에 경험이 부족한 연구자의 도입이 제한될 가능성이 있습니다. 이러한 제약이 있음에도 불구하고, 신약 개발 프로그램에 대한 관심이 높아지고, 연구 활동을 CRO(위탁 연구 기관)에 아웃소싱하는 추세가 확대되며, 바이오연료 생산 및 의약품 제조를 포함한 산업용 생명공학 공정에서 유능한 세포의 응용이 확대됨에 따라 큰 기회가 창출되어, 시장은 지속적인 성장 궤도에 오를 것으로 전망됩니다.
본 조사의 주요 특징
- 본 조사에서는 각 부문의 잠재적 수익 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채택하는 경쟁 전략에 관한 중요한 인사이트를 제공합니다.
- 본 조사에서는 다음의 매개변수를 바탕으로 전 세계 컴피턴트 셀 시장의 주요 기업 프로파일을 작성하였습니다. 기업 개요, 제품 포트폴리오, 주요 성과, 재무 실적, 전략
- 본 보고서의 인사이트를 활용함으로써, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대, 마케팅 전략에 관해 정보에 기반한 의사결정을 내릴 수 있게 됩니다.
- 전 세계 컴피턴트 셀 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진출기업, 금융 애널리스트 등 이 산업의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 전 세계 컴피턴트 셀 시장 분석에 활용되는 다양한 전략 매트릭스를 통해 의사결정을 수월하게 내릴 수 있습니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 컴피턴트 셀 시장 : 세포 유형별, 2021-2033년
제5장 세계의 컴피턴트 셀 시장 : 생물 유형별, 2021-2033년
제6장 세계의 컴피턴트 셀 시장 : 용도별, 2021-2033년
제7장 세계의 컴피턴트 셀 시장 : 컴피턴시 레벨별, 2021-2033년
제8장 세계의 컴피턴트 셀 시장 : 최종사용자별, 2021-2033년
제9장 세계의 컴피턴트 셀 시장 : 지역별, 2021-2033년
제10장 경쟁 구도
제11장 애널리스트의 제안
제12장 참고 문헌과 조사 방법
LSH 26.06.23Competent Cells Market is estimated to be valued at USD 2.73 Bn in 2026 and is expected to reach USD 5.45 Bn by 2033, growing at a compound annual growth rate (CAGR) of 10.4% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 2.73 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 10.40% | 2033 Value Projection: | USD 5.45 Bn |
The global competent cells market represents a critical segment within the biotechnology and pharmaceutical industry, serving as fundamental tools for molecular biology applications and genetic engineering processes. Competent cells are bacterial cells that have been chemically or physically treated to increase their permeability to DNA, enabling researchers to introduce foreign genetic material through transformation procedures. These specialized cells play an indispensable role in cloning, protein expression, plasmid propagation, and various recombinant DNA technologies that form the backbone of modern biotechnology research and development.
The market encompasses various types of competent cells, including chemically competent cells and electrocompetent cells, each designed for specific applications ranging from routine cloning to high-efficiency transformations. With the expanding scope of genomics research, personalized medicine initiatives, and biotechnology innovations, the demand for reliable and efficient competent cell systems continues to surge globally. Academic research institutions, pharmaceutical companies, biotechnology firms, and contract research organizations constitute the primary end users driving market growth through their continuous need for molecular cloning tools and genetic manipulation technologies that facilitate breakthrough discoveries in therapeutic development and scientific research.
Market Dynamics
The global competent cells market is propelled by several key drivers that collectively fuel its expansion across research and commercial applications. The increasing investment in genomics and proteomics research, coupled with the growing prevalence of genetic disorders requiring innovative therapeutic solutions, serves as a primary growth catalyst for market advancement. The rising adoption of synthetic biology approaches, CRISPR-Cas9 gene editing technologies, and personalized medicine initiatives significantly amplifies the demand for high-quality competent cells capable of facilitating complex genetic manipulations. Additionally, the expanding biotechnology sector, particularly in emerging economies, creates substantial opportunities for market penetration and revenue generation. However, the market faces notable restraints including stringent regulatory frameworks governing genetic research and biotechnology applications, which can delay product approvals and increase compliance costs for manufacturers.
The high cost associated with maintaining cold chain logistics and storage requirements for competent cells poses additional challenges, particularly for smaller research institutions with limited budgets. Furthermore, the technical complexity involved in handling competent cells and the requirement for specialized expertise may limit adoption among novice researchers. Despite these constraints, significant opportunities emerge from the increasing focus on drug discovery and development programs, the growing trend of outsourcing research activities to contract research organizations, and the expanding applications of competent cells in industrial biotechnology processes including biofuel production and pharmaceutical manufacturing, positioning the market for sustained growth trajectory.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global competent cells market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Thermo Fisher Scientific Inc, Merck KGaA Sigma Aldrich, Agilent Technologies Inc, Takara Bio Inc, New England Biolabs Inc, Promega Corporation, QIAGEN NV, Zymo Research Corp, Bio Rad Laboratories Inc, GenScript Biotech Corporation, OriGene Technologies Inc, Lucigen brand of LGC Biosearch Technologies, HiMedia Laboratories Pvt Ltd, Intact Genomics Inc, and Scarab Genomics LLC
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global competent cells market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global competent cells market
Market Segmentation
- Cell Type Insights (Revenue, USD Bn, 2021 - 2033)
- Chemically Competent Cells
- Electrocompetent Cells
- Ultracompetent Cells
- Organism Type Insights (Revenue, USD Bn, 2021 - 2033)
- Bacterial Competent Cells
- Yeast Competent Cells
- Mammalian Competent Cells
- Application Insights (Revenue, USD Bn, 2021 - 2033)
- Molecular Cloning and Subcloning
- Recombinant Protein Expression
- Plasmid and Library Construction (cDNA, genomic, phage, BAC/YAC libraries)
- Mutagenesis and Directed Evolution
- CRISPR/Cas and Genome Editing Workflows
- Synthetic Biology and Metabolic Engineering
- Viral Vector Construction and Packaging Support
- Other Applications (e.g., functional genomics, pathway screening)
- Competency Level Insights (Revenue, USD Bn, 2021 - 2033)
- High Efficiency Competent Cells
- Moderate Efficiency Competent Cells
- Low Efficiency Competent Cells
- End User Insights (Revenue, USD Bn, 2021 - 2033)
- Academic and Research Institutes
- Biotechnology and Biopharmaceutical Companies
- Contract Research Organizations (CROs)
- Diagnostic and Clinical Research Laboratories
- Industrial Microbiology and Synthetic Biology Companies
- Government and Non-Profit Research Organizations
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Thermo Fisher Scientific Inc
- Merck KGaA Sigma Aldrich
- Agilent Technologies Inc
- Takara Bio Inc
- New England Biolabs Inc
- Promega Corporation
- QIAGEN NV
- Zymo Research Corp
- Bio Rad Laboratories Inc
- GenScript Biotech Corporation
- OriGene Technologies Inc
- Lucigen brand of LGC Biosearch Technologies
- HiMedia Laboratories Pvt Ltd
- Intact Genomics Inc
- Scarab Genomics LLC
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Competent Cells Market, By Cell Type
- Global Competent Cells Market, By Organism Type
- Global Competent Cells Market, By Application
- Global Competent Cells Market, By Competency Level
- Global Competent Cells Market, By End User
- Global Competent Cells Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Competent Cells Market, By Cell Type, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Chemically Competent Cells
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Electrocompetent Cells
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Ultracompetent Cells
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
5. Global Competent Cells Market, By Organism Type, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Bacterial Competent Cells
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Yeast Competent Cells
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Mammalian Competent Cells
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
6. Global Competent Cells Market, By Application, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Molecular Cloning and Subcloning
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Recombinant Protein Expression
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Plasmid and Library Construction (cDNA, genomic, phage, BAC/YAC libraries)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Mutagenesis and Directed Evolution
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- CRISPR/Cas and Genome Editing Workflows
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Synthetic Biology and Metabolic Engineering
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Viral Vector Construction and Packaging Support
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Other Applications (e.g., functional genomics, pathway screening)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
7. Global Competent Cells Market, By Competency Level, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- High Efficiency Competent Cells
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Moderate Efficiency Competent Cells
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Low Efficiency Competent Cells
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
8. Global Competent Cells Market, By End User, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Academic and Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Biotechnology and Biopharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Contract Research Organizations (CROs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Diagnostic and Clinical Research Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Industrial Microbiology and Synthetic Biology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Government and Non-Profit Research Organizations
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
9. Global Competent Cells Market, By Region, 2021 - 2033, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Cell Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Organism Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Competency Level, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Cell Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Organism Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Competency Level, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Cell Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Organism Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Competency Level, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Cell Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Organism Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Competency Level, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Cell Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Organism Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Competency Level, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Cell Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Organism Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Competency Level, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
10. Competitive Landscape
- Thermo Fisher Scientific Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck KGaA Sigma Aldrich
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Agilent Technologies Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Takara Bio Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- New England Biolabs Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Promega Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- QIAGEN NV
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Zymo Research Corp
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bio Rad Laboratories Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- GenScript Biotech Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- OriGene Technologies Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Lucigen brand of LGC Biosearch Technologies
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- HiMedia Laboratories Pvt Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Intact Genomics Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Scarab Genomics LLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
11. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
12. References and Research Methodology
- References
- Research Methodology
- About us
